• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4698324)   Today's Articles (4391)
For: Strong J. Are there differences in the efficacy of once-weekly GLP-1RAs in patients with type 2 diabetes? J Am Assoc Nurse Pract 2018. [DOI: 10.1097/jxx.0000000000000113] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Number Cited by Other Article(s)
1
Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. J Am Assoc Nurse Pract 2018. [DOI: 10.1097/jxx.0000000000000115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
2
Safety of once-weekly glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes. J Am Assoc Nurse Pract 2018. [DOI: 10.1097/jxx.0000000000000112] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
3
The mode and mechanism of action of once-weekly glucagon-like peptide-1 receptor agonists in type 2 diabetes. J Am Assoc Nurse Pract 2018. [DOI: 10.1097/jxx.0000000000000114] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA